XML 26 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 1 - Organization
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

1.

Organization

 

Harvard Bioscience, Inc., a Delaware corporation (the “Company”), is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations (“CROs”). With operations in the United States, Europe and China, the Company sells through a combination of direct and distribution channels to customers around the world.